May 27, 2018 8:05 PM ET


Company Overview of Chiesi USA, Inc.

Company Overview

Chiesi USA, Inc., a specialty pharmaceutical company, engages in the research, development, production, and commercialization of products in the areas of cardiovascular, respiratory, neonatology, rare disease, and special care therapeutics to the healthcare community. Its products include CARDENE I.V., a nicardipine hydrochloride premixed injection; BETHKIS, a tobramycin inhalation solution; and CUROSURF, a poractant alfa intratracheal suspension solution. The company also provides PERTZYE, a pancrelipase delayed-release capsule; RETAVASE, a recombinant; ZYFLO, A zileuton tablet; and ZYFLO CR, a zileuton extended-release tablet. The company was formerly known as Cornerstone Therapeutics Inc....

1255 Crescent Green

Suite 250

Cary, NC 27518

United States

105 Employees



Key Executives for Chiesi USA, Inc.

Age: 52
Chief Financial Officer and Vice President of Finance
Principal Accounting Officer and Director of Accounting, Financial Planning & Analysis
Vice President of Clinical and Regulatory
Age: 54
Vice President of Strategy & Business Development
Age: 47
Compensation as of Fiscal Year 2017.

Chiesi USA, Inc. Key Developments

Chiesi Mulls Acquisitions

Chiesi USA, Inc. is looking for acquisitions. The company indicated that it continue to seek opportunities to acquire companies.

Chiesi USA Breaks Ground on New Headquarters Building in Cary

Chiesi USA broke ground on a new corporate headquarters building overlooking Symphony Lake in Cary. Chiesi will occupy two floors of Regency Woods II, a six-story development by The Spectrum Companies, located off of U.S. 64. Construction is scheduled for completion in the fourth quarter of 2018, and the move is part of a long-term growth strategy for Chiesi that includes product portfolio growth, staff increases, and expansion of the company's own Research and Development group.

Chiesi USA, Inc. Presents at 5th Annual Reimbursement and Access 2017, Aug-17-2017 10:45 AM

Chiesi USA, Inc. Presents at 5th Annual Reimbursement and Access 2017, Aug-17-2017 10:45 AM. Venue: Doubletree by Hilton Center City, 237 South Broad Street, Philadelphia, PA 19107, United States. Speakers: Marc Claussen, Director, Market Access.

Similar Private Companies By Industry

Company Name Region
Praetego, Inc. United States
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Chiesi USA, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at